Show simple item record

dc.contributor.authorGilley, Jonathan
dc.contributor.authorJackson, Oscar
dc.contributor.authorPipis, Menelaos
dc.contributor.authorEstiar, Mehrdad A
dc.contributor.authorAl-Chalabi, Ammar
dc.contributor.authorDanzi, Matt C
dc.contributor.authorvan Eijk, Kristel R
dc.contributor.authorGoutman, Stephen A
dc.contributor.authorHarms, Matthew B
dc.contributor.authorHoulden, Henry
dc.contributor.authorIacoangeli, Alfredo
dc.contributor.authorKaye, Julia
dc.contributor.authorLima, Leandro
dc.contributor.authorRavits, John
dc.contributor.authorRouleau, Guy A
dc.contributor.authorSchüle, Rebecca
dc.contributor.authorXu, Jishu
dc.contributor.authorZüchner, Stephan
dc.contributor.authorCooper-Knock, Johnathan
dc.contributor.authorGan-Or, Ziv
dc.contributor.authorReilly, Mary M
dc.contributor.authorColeman, Michael
dc.description.abstractSARM1, a protein with critical NADase activity, is a central executioner in a conserved programme of axon degeneration. We report seven rare missense or in-frame microdeletion human SARM1 variant alleles in patients with amyotrophic lateral sclerosis (ALS) or other motor nerve disorders that alter the SARM1 auto-inhibitory ARM domain and constitutively hyperactivate SARM1 NADase activity. The constitutive NADase activity of these seven variants is similar to that of SARM1 lacking the entire ARM domain and greatly exceeds the activity of wild-type SARM1, even in the presence of nicotinamide mononucleotide (NMN), its physiological activator. This rise in constitutive activity alone is enough to promote neuronal degeneration in response to otherwise non-harmful, mild stress. Importantly, these strong gain-of-function alleles are completely patient-specific in the cohorts studied and show a highly significant association with disease at the single gene level. These findings of disease-associated coding variants that alter SARM1 function build on previously reported genome-wide significant association with ALS for a neighbouring, more common SARM1 intragenic single nucleotide polymorphism (SNP) to support a contributory role of SARM1 in these disorders. A broad phenotypic heterogeneity and variable age-of-onset of disease among patients with these alleles also raises intriguing questions about the pathogenic mechanism of hyperactive SARM1 variants.
dc.publishereLife Sciences Publications, Ltd
dc.rightsAttribution 4.0 International
dc.titleEnrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders.
dc.contributor.orcidGilley, Jonathan [0000-0002-9510-7956]
dc.contributor.orcidJackson, Oscar [0000-0002-1825-9331]
dc.contributor.orcidGan-Or, Ziv [0000-0003-0332-234X]
dc.contributor.orcidColeman, Michael [0000-0002-9354-532X]
rioxxterms.typeJournal Article/Review
pubs.funder-project-idBiotechnology and Biological Sciences Research Council (BB/S009582/1)
cam.orpheus.success2022-03-02: VoR added to Apollo record

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International